This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Samantha Shaddock

Before joining TheStreet.com in June 2007, Shaddock spent six years at The Dallas Morning News, where she worked as a copy editor and helped launch Quick, a publication for young commuters. She received her English degree from the University of Texas at Arlington.

Samantha Shaddock
By This Author:
« Back
Page 1 of 21

Health Stock Winners and Losers: Bristol, Glaxo

By Samantha Shaddock

Bristol announces it will reaffirm its earnings guidance, and Glaxo acquires a 16% stake in South African firm Aspen Pharmacare.

03:12PM 05/12/09

Health Winners and Losers: AstraZeneca

By Samantha Shaddock

AstraZeneca's blood-thinner outperforms Plavix in a late-stage trial, and Baxter's heparin is being investigated, according to a report.

05:26PM 05/11/09

AT&T Near Deal to Buy Alltel Assets: Report

By Samantha Shaddock

AT&T is reportedly close to a $2.5 billion deal to buy pieces of Alltel Corp. from Verizon.

05:04PM 05/08/09

Chips Pummeled; Nvidia Swings to Loss

By Samantha Shaddock

Widely held semiconductor stocks get a blistering, and Nvidia swings to a loss.

06:35PM 05/07/09

Google's Schmidt: Why Would I Leave Apple's Board?

By Samantha Shaddock

Google's CEO says he doesn't plan to resign from Apple's board despite a federal antitrust investigation.

06:26PM 05/07/09

Glaxo Unloads U.S. Wellbutrin Rights for $510M

By Samantha Shaddock

GlaxoSmithKline is divesting its U.S. rights to Wellbutrin, sales of which have slipped 70%, as part of its strategy to reshape its U.S. business.

06:08PM 05/06/09

Genentech's Avastin Gets Faster OK for Brain Cancer

By Samantha Shaddock

Genentech says the FDA has granted accelerated approval of its drug Avastin to treat a type of brain cancer.

06:03PM 05/06/09

Chip Stocks: Intel, Atmel Get Soggy

By Samantha Shaddock

Investors dunk Intel in the red, and Atmel gets downgraded amid disappointing quarterly sales.

05:30PM 05/06/09

Tech Winners and Losers: Microsoft Cuts

By Samantha Shaddock

Microsoft reportedly follows through on cuts announed in January.

06:17PM 05/05/09

Intel, Other Chips Lead Tech Higher

By Samantha Shaddock

Chip stocks are leading the tech sector higher, with Intel and AMD among the biggest winners.

03:32PM 05/04/09

« Back
Page 1 of 21

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs